Truzo is the world’s first rebate system for the 340B Drug Discount Program. It is a two-sided platform for drug manufacturers and covered entities (qualified pharmacies and hospitals) to work together to determine discount compliance (should this rebate be paid?) and facilitate payment between each other.

The 340B Program is growing rapidly–in 2023 discounted purchases totalled $66 billion, an increase in 23.4% from 2022-2023. Kalderos has found there is 3-5% error in preventing duplicate discounts in the current system, where Covered Entities buy drugs upfront at a discounted price. They then work with manufacturers to effectuate the discounts (make sure all eligible patients are receiving the discounts they’re entitled to), and ensure there are no ‘duplicate discounts’, aka crossover discounts with Medicaid, Medicare and commercial (insurance) discounts. 

This is due to inadequate infrastructure, outdated technology and data silos among the stakeholders. Kalderos believes a modern approach utilizing data and good product design can solve this problem.